RPXDs Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 4

RPXDs General Information

Description

Developer of advanced drug research and development technology designed to bridge applied basic research and new drug creation. The company offers cutting-edge scientific discoveries and starts from the three-dimensional structure of the drug target, taking the computational chemistry-driven drug molecule design method as the core, integrating biochemistry, structural biology, cell biology, transgenic animal models and other multidisciplinary technical methods, thereby providing drug discovery enterprises with multiple new drug candidates in the treatment fields of obesity and obesity-related metabolic diseases, irritable bowel syndrome, cancer and autoimmune diseases.

Contact Information

Website
www.rpxds.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 703, Building B1, BioNano Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit 703, Building B1, BioNano Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RPXDs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 27-Feb-2023 Completed Generating Revenue
2. Later Stage VC 19-Aug-2019 Completed Generating Revenue
1. Seed Round 11-Nov-2014 Completed Startup
To view RPXDs’s complete valuation and funding history, request access »

RPXDs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RPXDs Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AB Magnitude Ventures Group Venture Capital Minority
Dawu Venture Capital Venture Capital Minority
Trinity Innovation Fund Venture Capital Minority
YuanBio Venture Capital Venture Capital Minority
To view RPXDs’s complete investors history, request access »

RPXDs FAQs

  • When was RPXDs founded?

    RPXDs was founded in 2014.

  • Where is RPXDs headquartered?

    RPXDs is headquartered in Suzhou, China.

  • What is the size of RPXDs?

    RPXDs has 5 total employees.

  • What industry is RPXDs in?

    RPXDs’s primary industry is Drug Discovery.

  • Is RPXDs a private or public company?

    RPXDs is a Private company.

  • What is the current valuation of RPXDs?

    The current valuation of RPXDs is .

  • What is RPXDs’s current revenue?

    The current revenue for RPXDs is .

  • How much funding has RPXDs raised over time?

    RPXDs has raised $4.31M.

  • Who are RPXDs’s investors?

    AB Magnitude Ventures Group, Dawu Venture Capital, Trinity Innovation Fund, and YuanBio Venture Capital have invested in RPXDs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process